Polatuzumab, Rituximab and Orelabrutinib Combination Regimen (PRO) in the Treatment of Elderly Frail Patients with Treatment-naive Non-GCB DLBCL
Clinical trial NCT06530511 · UNKNOWN
Trial details
- NCT number
- NCT06530511
- Sponsor
- Affiliated Hospital of Nantong University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2026-02-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.